FBXO22 and lung carcinoma: The TCGA dataset analysis showed that the negative correlation between FBXO22 expression and OS could not be found in patients with mutation or deletion LKB1 expression (Fig. 1g–j), suggesting the potential link of FBXO22 and LKB1 in lung cancer.